In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…
Age is the major risk factor for Alzheimer’s — approximately 10 percent of people over the age of 65 develop the disease. As cases…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Some of the United States’s most widespread…
Good news for brain health this summer: FDA-approved drugs like Leqembi available for Alzheimer’s are becoming more widely available. The caveat: These drugs only…
One in three people with dementia develop chronic pain. When over-the-counter medications like Aspirin or Aleve aren’t enough, doctors may prescribe opioids: a class…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
There are at least 6 million Americans living with Alzheimer’s disease. But some counties have much higher rates of Alzheimer’s than others. Today at…
Drugmaker Alzheon is currently running clinical trials on a new disease-modifying Alzheimer’s treatment: valiltramiprosate, or ALZ-801. While, like the new buzzy new Alzheimer’s monoclonal…
This article was made possible through sponsorship by Lexeo Therapeutics. Being Patient’s editorial team produced the interview and article with no review/approval process by the…
An estimated 500,000 people in the U.S. are diagnosed with dementia each year. The diagnosis is often accompanied with substantial life changes. For example,…
“If it’s good for your heart, it’s good for your brain.” This is long-standing wisdom in the medical community, says Dr. Gregory Jicha, a neurology…
When a person is diagnosed with dementia or another debilitating disease or illness, family members are often the first to step up and help….
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. As neurodegenerative diseases like Alzheimer’s disease become…
Sometimes, the proteins in the body stop doing their jobs. They turn into polluting plaques, tangles and globs that can build up in the…
Have you heard of Wegovy, Ozempic, and Mounjaro? These new medications — that muffle hunger signals in the brain — are all the rage….